Skip to main content
    Home/Brands/Bella Bellissima
    Brand Profile

    Bella Bellissima

    Bella Bellissima is a London-based independent fragrance house founded by perfumer Bella Crane. The brand earned placement at Harrods, one of London's most prestigious department stores, and built its collection around what the house describes as unique, artisanal perfumery. The range spans woody, oriental, and fresh scent families across twelve distinct fragrances, including Noble Incense, Arabian Rose, and Velvet Santal. Crane trained in Paris and Grasse, the historic heart of French perfumery, bringing formal education to her work as both designer and entrepreneur. The brand maintains vegan and cruelty-free formulations throughout its collection.

    United KingdomEst. 2010
    11
    Fragrances
    4.5
    Avg rating
    Shop the collection
    SignatureWhite Leather
    White Leather
    EDP
    Community
    4.5
    Average rating
    across 11 fragrances
    Collection
    11
    Fragrances and counting
    Heritage
    2010
    Founded in United Kingdom

    Heritage

    A house, in its own words

    Bella Bellissima emerged from Bella Crane's personal journey into the art of perfumery. She pursued formal training in both Paris and Grasse, the Provencal city synonymous with fragrance production for centuries. Upon completing her education, she launched the house with an initial collection of four fragrances. The brand operated from London, building a reputation through direct-to-consumer sales via its website before securing retail partnerships. Harrods became a key stockist, placing the independent house alongside established luxury fragrance brands on the iconic department floor. The brand emphasizes its artisan approach, positioning itself as a creator of distinctive scents rather than a mass-market producer. Crane's role as both perfumer and designer set the tone for a house with personal creative control over every aspect of its identity, from formulation to presentation.

    Bella Bellissima operates on the principle that fragrance should be a personal statement rather than a commercial trend. The house focuses on what it terms unique perfumery, suggesting an emphasis on distinctive compositions over safe, commercially proven formulas. Crane's training in Grasse informed a classical approach to fragrance construction, yet the brand's output shows range across scent families. The cruelty-free and vegan commitment shapes formulation choices, requiring alternatives to traditional animal-derived materials like musk or ambergris. The London base influences a certain British restraint in presentation, even as the scents themselves venture into bold oriental territory with ingredients like oud, saffron, and rose. The house presents itself as an accessible alternative to heritage houses, offering artisanal quality without the weight of centuries-old tradition.

    2010
    Bella Bellissima founded by Bella Crane in London after her training in Paris and Grasse
    2010
    Initial collection of four fragrances launched
    2011
    Royal Saffron and Arabian Rose introduced, early additions to the lineup
    2013
    Emerald Oud released, expanding into woody oriental territory
    2014
    Velvet Santal and Riviera Lime added, showing range across scent families
    2015
    Bohemia Garnet and Tombee De Le Nuit launched, marking continued collection growth

    Did you know?

    Interesting facts

    01

    Founder Bella Crane trained in both Paris and Grasse, the French city where perfume-making has been practiced for over four centuries.

    02

    The brand secured placement at Harrods, London's oldest department store, despite operating as an independent house rather than a major fragrance conglomerate.

    03

    The collection maintains vegan and cruelty-free formulations across all twelve fragrances, avoiding traditional animal-derived ingredients like civet, ambergris, and castoreum.

    04

    Bella Bellissima describes itself as The House of Unique Parfum, a self-designation emphasizing distinctive compositions over commercially safe formulations.